Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome.
Bypass
Critical-threatening limb ischemia
Diabetes
Major amputation
Percutaneous transluminal angioplasty
Revascularization
Journal
Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299
Informations de publication
Date de publication:
04 Oct 2023
04 Oct 2023
Historique:
received:
15
08
2023
accepted:
11
09
2023
medline:
4
10
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
aheadofprint
Résumé
To report a review and meta-analysis of all randomized controlled trials (RCTs) comparing bypass surgery (BS) and endovascular treatment (ET) in infrainguinal peripheral arterial disease (PAD) for several endpoints, such as major and minor amputation, major adverse limb events (MALEs), ulcer healing, time to healing, and all-cause mortality to support the development of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome (DFS). A MEDLINE and EMBASE search was performed to identify RCTs, published since 1991 up to June 21, 2023, enrolling patients with lower limb ischemia due to atherosclerotic disease (Rutherford I-VI). Any surgical BS or ET was allowed, irrespective of the approach, route, or graft employed, from iliac to below-the-knee district. Primary endpoint was major amputation rate. Secondary endpoints were amputation-free survival major adverse limb events (MALEs), minor amputation rate, all-cause mortality, ulcer healing rate, time to healing, pain, transcutaneous oxygen pressure (T
Identifiants
pubmed: 37792028
doi: 10.1007/s00592-023-02185-x
pii: 10.1007/s00592-023-02185-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Andrea Bernetti
(A)
Corrado Bordieri
(C)
Cristina Cappella
(C)
Alessandro De Cassai
(A)
Marco Falcone
(M)
Mauro Gargiulo
(M)
Valentina Lorenzoni
(V)
Gerardo Medea
(G)
Cesare Miranda
(C)
Matteo Monami
(M)
Luca Monge
(L)
Alessia Scatena
(A)
Germano Scevola
(G)
Eugenio Stabile
(E)
Laura Stefanon
(L)
Rodolfo Tramonta
(R)
Cristiana Vermigli
(C)
Antonio Volpe
(A)
Luigi Uccioli
(L)
Informations de copyright
© 2023. Springer-Verlag Italia S.r.l., part of Springer Nature.
Références
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, GVG Writing Group (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. https://doi.org/10.1016/j.jvs.2019.02.016
doi: 10.1016/j.jvs.2019.02.016
pubmed: 31870756
pmcid: 7141750
Kim TI, Mena C, Sumpio BE (2020) The role of lower extremity amputation in chronic limb-threatening ischemia. Int J Angiol 29(3):149–155. https://doi.org/10.1055/s-0040-1710075 . (In eng)
doi: 10.1055/s-0040-1710075
pubmed: 32904807
pmcid: 7458760
Martelli E, Zamboni M, Sotgiu G et al (2023) Sex-related differences and factors associated with peri-procedural and 1 year mortality in chronic limb-threatening ischemia patients from the CLIMATE Italian registry. J Pers Med 13(2):316. https://doi.org/10.3390/jpm13020316]
doi: 10.3390/jpm13020316]
pubmed: 36836550
pmcid: 9959358
Farber A, Menard MT, Conte MS et al (2022) Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 387(25):2305–2316. https://doi.org/10.1056/NEJMoa2207899 . (In eng)
doi: 10.1056/NEJMoa2207899
pubmed: 36342173
Setacci C, Sirignano P, Galzerano G et al (2013) Endovascular first as “preliminary approach” for critical limb ischemia and diabetic foot. J Cardiovasc Surg (Torino) 54(6):679–684
pubmed: 24126506
Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB et al (2015) The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62:1642e1651e3
El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS (2022) Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia. J Vasc Surg 76(4):997-1005.e2. https://doi.org/10.1016/j.jvs.2022.04.042 . (Epub 2022 Jun 10)
doi: 10.1016/j.jvs.2022.04.042
pubmed: 35697305
Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH (2018) A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 68(2):624–633. https://doi.org/10.1016/j.jvs.2018.01.066 . (Epub 2018 May 24)
doi: 10.1016/j.jvs.2018.01.066
pubmed: 29804736
Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N (2008) Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 47(5):975–981. https://doi.org/10.1016/j.jvs.2008.01.005 . (In eng)
doi: 10.1016/j.jvs.2008.01.005
pubmed: 18372148
Tsai TT, Rehring TF, Rogers RK, Shetterly SM, Wagner NM, Gupta R et al (2015) The contemporary safety and effectiveness of lower extremity bypass surgery and peripheral endovascular interventions in the treatment of symptomatic peripheral arterial disease. Circulation 132:1999–2011
doi: 10.1161/CIRCULATIONAHA.114.013440
pubmed: 26362632
pmcid: 4652630
Jones WS, Dolor RJ, Hasselblad V, Vemulapalli S, Subherwal S, Schmit K et al (2014) Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am Heart J 167:489–98.e7
doi: 10.1016/j.ahj.2013.12.012
pubmed: 24655697
Siracuse JJ, Van Orden K, Kalish JA, Eslami MH, Schermerhorn ML, Patel VI et al (2017) Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg 65:1039–1046
doi: 10.1016/j.jvs.2016.10.078
pubmed: 28041804
Antoniou GA, Georgiadis GS, Antoniou SA, Makar RR, Smout JD, Torella F (2017) Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev 4(4):Cd002000. https://doi.org/10.1002/14651858.CD002000.pub3 . (In eng)
doi: 10.1002/14651858.CD002000.pub3
pubmed: 28368090
Antonopoulos CN, Mylonas SN, Moulakakis KG et al (2017) A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions. J Vasc Surg 65(1):234. https://doi.org/10.1016/j.jvs.2016.08.095 . (In eng)
doi: 10.1016/j.jvs.2016.08.095
pubmed: 27865639
Fowkes F, Leng GC (2008) Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev 2:Cd002000. https://doi.org/10.1002/14651858.CD002000.pub2 . (In eng)
doi: 10.1002/14651858.CD002000.pub2
Zhang R, Ni L, Zeng R et al (2021) An indirect comparison by Bayesian network meta-analysis of drug-coated devices versus saphenous vein graft bypass in femoropopliteal arterial occlusive disease. J Vasc Surg 74(2):478-486.e11. https://doi.org/10.1016/j.jvs.2020.11.054 . (In eng)
doi: 10.1016/j.jvs.2020.11.054
pubmed: 33600930
McQuade K, Gable D, Hohman S, Pearl G, Theune B (2009) Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 49(1):109–15. https://doi.org/10.1016/j.jvs.2008.08.041 . (In eng)
doi: 10.1016/j.jvs.2008.08.041
pubmed: 19028055
Björkman P, Auvinen T, Hakovirta H et al (2018) Drug-eluting stent shows similar patency results as prosthetic bypass in patients with femoropopliteal occlusion in a randomized trial. Ann Vasc Surg 53:165–170. https://doi.org/10.1016/j.avsg.2018.04.014 . (In eng)
doi: 10.1016/j.avsg.2018.04.014
pubmed: 29886215
Bradbury AW, Moakes CA, Popplewell M et al (2023) A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 401(10390):1798–1809. https://doi.org/10.1016/s0140-6736(23)00462-2 . (In eng)
doi: 10.1016/s0140-6736(23)00462-2
pubmed: 37116524
Monami M, Scatena A, Miranda C., et al. (2023) Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol
Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158–72. https://doi.org/10.1016/j.jclinepi.2012.01.012 . (In eng)
doi: 10.1016/j.jclinepi.2012.01.012
pubmed: 22609141
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 339:b2700. https://doi.org/10.1136/bmj.b2700
doi: 10.1136/bmj.b2700
pubmed: 19622552
pmcid: 2714672
Moher D, Liberati A, Tetziaff J, and D.G.J.A.o.i.m. Altman 2009 Vol.151 Issue 4 Pages 264–269.
Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj 343:d5928. https://doi.org/10.1136/bmj.d5928 . (In eng)
doi: 10.1136/bmj.d5928
pubmed: 22008217
pmcid: 3196245
Katsamouris A, Brewster DC, Megerman J, Cina C, Darling RC, Abbott WM (1984) Transcutaneous oxygen tension in selection of amputation level. Am J Surg 147(4):510–517. https://doi.org/10.1016/0002-9610(84)90014-x . (In eng)
doi: 10.1016/0002-9610(84)90014-x
pubmed: 6711754
Greenland P, Smith SC Jr, Grundy SM (2001) Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104(15):1863–1867. https://doi.org/10.1161/hc4201.097189 . (In eng)
doi: 10.1161/hc4201.097189
pubmed: 11591627
Holm J, Arfvidsson B, Jivegård L et al (1991) Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 5(5):517–522. https://doi.org/10.1016/s0950-821x(05)80338-x . (In eng)
doi: 10.1016/s0950-821x(05)80338-x
pubmed: 1835704
Bergan JJ, Wilson SE, Wolf G, Deupree RH (1992) Unexpected, late cardiovascular effects of surgery for peripheral artery disease. Veterans Affairs Cooperative Study 199. Arch Surg 127(9):1119–1123. https://doi.org/10.1001/archsurg.1992.01420090127019 . (In eng)
doi: 10.1001/archsurg.1992.01420090127019
pubmed: 1387528
Lepäntalo M, Laurila K, Roth WD et al (2009) PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial. Eur J Vasc Endovasc Surg 37(5):578–584. https://doi.org/10.1016/j.ejvs.2009.01.003 . (In eng)
doi: 10.1016/j.ejvs.2009.01.003
pubmed: 19231250
van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ (2004) Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 28(2):132–137. https://doi.org/10.1016/j.ejvs.2004.04.003 . (In eng)
doi: 10.1016/j.ejvs.2004.04.003
pubmed: 15234692
Eleissawy MI, Elbarbary AH, Elwagih MM, Elheniedy MA, Santoso C, Fourneau I (2019) Ipsilateral antegrade angioplasty for flush superficial femoral artery occlusion versus open bypass surgery. Ann Vasc Surg 61:55–64. https://doi.org/10.1016/j.avsg.2019.05.062 . (In eng)
doi: 10.1016/j.avsg.2019.05.062
pubmed: 31394228
Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366(9501):1925–34. https://doi.org/10.1016/s0140-6736(05)67704-5 . (In eng)
doi: 10.1016/s0140-6736(05)67704-5
pubmed: 16325694
Enzmann FK, Nierlich P, Aspalter M et al (2019) Nitinol stent versus bypass in long femoropopliteal lesions: 2-year results of a randomized controlled trial. JACC Cardiovasc Interv 12(24):2541–2549. https://doi.org/10.1016/j.jcin.2019.09.006 . (In eng)
doi: 10.1016/j.jcin.2019.09.006
pubmed: 31786218
Gouëffic Y, Della Schiava N, Thaveau F et al (2017) Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv 10(13):1344–1354. https://doi.org/10.1016/j.jcin.2017.03.046 . (In eng)
doi: 10.1016/j.jcin.2017.03.046
pubmed: 28683941
Pecoraro RE, Reiber GE, Burgess EM (1990) Pathways to diabetic limb amputation. Basis for prevention Diabetes Care 13(5):513–521. https://doi.org/10.2337/diacare.13.5.513
doi: 10.2337/diacare.13.5.513
pubmed: 2351029
Tsetis D, Belli AM (2004) The role of infrapopliteal angioplasty. Br J Radiol 77(924):1007–1015. https://doi.org/10.1259/bjr/97382129
doi: 10.1259/bjr/97382129
pubmed: 15569642
Gottrup F (1994) Physiology and measurement of tissue perfusion. Ann Chir Gynaecol 83(3):183–189
pubmed: 7857061
Niinikoski J (1980) Cellular and nutritional interactions in healing wounds. Med Biol 58(6):3039
Gatti C, Cecchini S, Fabbietti P, Romagnoli F, Ricci S (2018) Endovascular treatment of diabetic peripheral arterial disease in older and oldest old patients: a retrospective study. Aging Clin Exp Res 30(2):205–207. https://doi.org/10.1007/s40520-017-0760-5 . (Epub 2017 Jun 3)
doi: 10.1007/s40520-017-0760-5
pubmed: 28584901
https://iwgdfguidelines.org/pad-guideline-2023/ August 11th 2023